BR9612578A - 4,5 DidronaftÚ1,2-c¾ isoxazóis e seus derivedos tendo atividade no scn - Google Patents

4,5 DidronaftÚ1,2-c¾ isoxazóis e seus derivedos tendo atividade no scn

Info

Publication number
BR9612578A
BR9612578A BR9612578A BR9612578A BR9612578A BR 9612578 A BR9612578 A BR 9612578A BR 9612578 A BR9612578 A BR 9612578A BR 9612578 A BR9612578 A BR 9612578A BR 9612578 A BR9612578 A BR 9612578A
Authority
BR
Brazil
Prior art keywords
isoxazoles
scn
derivatives
activity
Prior art date
Application number
BR9612578A
Other languages
English (en)
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of BR9612578A publication Critical patent/BR9612578A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9612578A 1996-01-05 1996-12-12 4,5 DidronaftÚ1,2-c¾ isoxazóis e seus derivedos tendo atividade no scn BR9612578A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05
PCT/US1996/019569 WO1997025317A1 (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Publications (1)

Publication Number Publication Date
BR9612578A true BR9612578A (pt) 1999-07-27

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612578A BR9612578A (pt) 1996-01-05 1996-12-12 4,5 DidronaftÚ1,2-c¾ isoxazóis e seus derivedos tendo atividade no scn

Country Status (14)

Country Link
EP (1) EP0874833A1 (pt)
JP (1) JP3161737B2 (pt)
KR (1) KR100308748B1 (pt)
CN (1) CN1214046A (pt)
AR (1) AR005347A1 (pt)
AU (1) AU710059B2 (pt)
BR (1) BR9612578A (pt)
CA (1) CA2241845C (pt)
HU (1) HUP9903706A3 (pt)
IL (1) IL125197A0 (pt)
NO (1) NO983100L (pt)
NZ (1) NZ325587A (pt)
WO (1) WO1997025317A1 (pt)
ZA (1) ZA9725B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050131051A1 (en) * 2000-08-21 2005-06-16 Shaomeng Wang 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon
NZ536109A (en) * 2002-04-02 2006-06-30 Janssen Pharmaceutica Nv Substituted amino isoxazoline derivatives and their use as anti-depressants
TW200409777A (en) 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
EP1554286B1 (en) * 2002-08-15 2010-01-27 Janssen Pharmaceutica N.V. Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
AU2003271567B2 (en) * 2002-08-21 2009-12-24 Janssen Pharmaceutica N.V. C6- and C9-substituted chromeno (4, 3-C) isoxazoline derivatives and their use as anti-depressants
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
EP2493866A1 (en) 2009-10-29 2012-09-05 Bristol-Myers Squibb Company Tricyclic heterocyclic compounds
WO2018045149A1 (en) 2016-09-02 2018-03-08 Bristol-Myers Squibb Company Substituted tricyclic heterocyclic compounds
US11046646B2 (en) 2017-08-09 2021-06-29 Bristol-Myers Squibb Company Alkylphenyl compounds
WO2019032631A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company OXIME ETHER COMPOUNDS
KR102002633B1 (ko) 2018-07-19 2019-07-22 김태효 완충이격부가 구비된 논슬립 발의류
KR102429797B1 (ko) 2019-12-31 2022-08-05 주식회사 제이패션 기능성 무재봉 덧신 및 이를 제조하는 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
ES2076253T3 (es) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
US5670522A (en) * 1992-10-23 1997-09-23 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands

Also Published As

Publication number Publication date
HUP9903706A2 (hu) 2000-08-28
CA2241845C (en) 2002-10-01
CA2241845A1 (en) 1997-07-17
NO983100L (no) 1998-09-04
IL125197A0 (en) 1999-03-12
AR005347A1 (es) 1999-04-28
CN1214046A (zh) 1999-04-14
ZA9725B (en) 1997-07-07
JPH11510816A (ja) 1999-09-21
NZ325587A (en) 1999-02-25
KR100308748B1 (ko) 2001-12-12
KR19990077033A (ko) 1999-10-25
JP3161737B2 (ja) 2001-04-25
HUP9903706A3 (en) 2000-09-28
WO1997025317A1 (en) 1997-07-17
AU1412697A (en) 1997-08-01
NO983100D0 (no) 1998-07-03
EP0874833A1 (en) 1998-11-04
AU710059B2 (en) 1999-09-09

Similar Documents

Publication Publication Date Title
DE3887830D1 (de) Viskoelastische Reinigungsmittel und deren Anwendung.
DE68921469D1 (de) Peptidderivate und deren verwendung.
DE58907433D1 (de) Schwingungsdämpfende und schwingungskompensierende Lageranordnung.
BR9703788A (pt) Sulfonamidas e seu uso
BR9509700A (pt) Diidropirimidina e seus usos
FI960717A0 (fi) Polyolefiiniseokset ja niiden prosessointi kiinteässä tilassa
BR9708902A (pt) Derivados de benzofurila e seu uso
DE68917726T2 (de) Verschluss- und öffnungsanordnung.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
EE9800378A (et) Alküülaminobensotiasooli ja -bensoksasooli derivaadid
BR9612578A (pt) 4,5 DidronaftÚ1,2-c¾ isoxazóis e seus derivedos tendo atividade no scn
DK0721457T3 (da) 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet
NO955305D0 (no) Optisk aktive benzotiepinderivater, deres fremstilling og anvendelse
BR9703601A (pt) Derivados de triazina e seu uso
DE3860711D1 (de) Mittel gegen protozoen bei insekten.
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
FI964267A0 (fi) Porfosyaniini ja CNC-laajennetut porfyriinit
BR9703378A (pt) Compostos de estilbeno e seu uso
NO972502D0 (no) 1,4-Diaryl-2-fluor-2-butan-insekticid- og akaricid-midler
BR9507675A (pt) Produtos sinterizados tendo densidade melhorada
HUP9904091A3 (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
DE68906340T2 (de) Tetrahydronaphthalin und indan-derivate.
FR2699058B1 (fr) Sieges modulaires et demontables.
TR25252A (tr) BENFLUTRIN VE PRALLETRIN IHTIVA EDEN PIRETROID TüRü AKTIF BILESIK KOMBINASYONLARI
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE, COM BASE NOS ARTIGOS 24, 25 E 8 DA LEI 9.279/96.